will compounded semaglutide be banned π¨ FDA Moves to Permanently Shut Down GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like and tirzepatide, signaling a major shift in how these FDA moves to remove GLP-1
Description
The results of the SURPASS-CVOT will define the impact of tirzepatide on cardiovascular disease

Results also showed that patients in the symptomatic group suffered mainly from reduced range of motion (ROM) of the shoulders and shoulder pain (Table 1)

Safe Exercise While Breastfeeding Start with walking, light strength training, or yoga
Therapeutic efforts aimed at neutralizing these pathological processes have thus far yielded limited results

Tuduri E, Lopez M, Dieguez C, Nadal A, Nogueiras R
